Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting

Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting

Abstract Background Chemotherapy-induced nausea and/or vomiting (CINV) is an intractable adverse effect of anticancer drugs. Although prophylactic use of fosaprepitant may be effective in reducing CINV, there is a lack of studies evaluating the application of fosaprepitant in real world. Aims and me...

Full description

Saved in:
Bibliographic Details
Main Authors: Lijuan He, Jize Wang, Weigao Pu, Haiyuan Li, Ben Liu, Zhuanfang Wang, Qinying Han, Yunpeng Wang, Bo Xu, Jike Hu, Guodong Sun, Hao Chen
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Fosaprepitant
Chemotherapy-induced nausea and vomiting
Pan-cancer
Real world
Online Access:https://doi.org/10.1186/s12885-025-13469-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-13469-6

Similar Items